MELISSA FARRIS: Open Payments
NPI 1205259942 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 44 payments from 16 companies in 2025. Trend: 2023 $283 · 2024 $744 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $243 |
| ABBVIE INC. | 11 | $192 |
| Astellas Pharma US Inc | 4 | $94 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Amgen Inc. | 3 | $51 |
| Insulet Corporation | 2 | $41 |
| Lilly USA, LLC | 2 | $30 |
| PFIZER INC. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: BREZTRI, VRAYLAR, Veozah, CAPLYTA, QULIPTA, UBRELVY, Omnipod, Auvelity.
Industry payments across MO — which companies pay providers there.
